Features May 2011 Issue

RA Therapies May Reduce Dementia Risk

Anti-TNF therapies, commonly used to treat the symptoms of rheumatoid arthritis (RA), may potentially reduce the risk of Alzheimer’s disease. Amyloidosis, a complication of chronic inflammation of RA caused by excess deposits of amyloid proteins in certain organs, can affect the normal function of other organs. Patients with Alzheimer’s dementia typically have local deposits of a type of amyloid protein in the brain.

To continue reading this article you must be a paid subscriber.

Subscribe to Arthritis Advisor

Arthritis Advisor is the first magazine published by one one of the world's leading orthopaedic hospitals specifically for people with arthritis.

Subscriber Log In

Forgot your password? Click Here.

Already subscribe but haven't registered for all the benefits of the website? Click here.